| Product Code: ETC9937708 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Antimycotic Drugs Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Antimycotic Drugs Market - Industry Life Cycle |
3.4 United Kingdom (UK) Antimycotic Drugs Market - Porter's Five Forces |
3.5 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Antimycotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of fungal infections in the United Kingdom |
4.2.2 Growing awareness about the importance of early treatment of fungal infections |
4.2.3 Technological advancements leading to the development of more effective antimycotic drugs |
4.3 Market Restraints |
4.3.1 High cost associated with antimycotic drugs |
4.3.2 Limited availability of advanced treatment options in certain regions of the UK |
4.3.3 Growing concern over antimicrobial resistance affecting the efficacy of antimycotic drugs |
5 United Kingdom (UK) Antimycotic Drugs Market Trends |
6 United Kingdom (UK) Antimycotic Drugs Market, By Types |
6.1 United Kingdom (UK) Antimycotic Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume, By Azoles, 2021- 2031F |
6.1.4 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume, By Polyenes, 2021- 2031F |
6.1.5 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume, By Allylamines, 2021- 2031F |
6.2 United Kingdom (UK) Antimycotic Drugs Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume, By Amphotericin B, 2021- 2031F |
6.2.3 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume, By Antifungal Therapy for Invasive and Serious Mycoses, 2021- 2031F |
6.3 United Kingdom (UK) Antimycotic Drugs Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Antimycotic Drugs Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United Kingdom (UK) Antimycotic Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 United Kingdom (UK) Antimycotic Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United Kingdom (UK) Antimycotic Drugs Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Antimycotic Drugs Market Export to Major Countries |
7.2 United Kingdom (UK) Antimycotic Drugs Market Imports from Major Countries |
8 United Kingdom (UK) Antimycotic Drugs Market Key Performance Indicators |
8.1 Number of reported cases of fungal infections in the UK |
8.2 Research and development investment in antimycotic drugs |
8.3 Adoption rate of new antimycotic drug treatments |
8.4 Number of healthcare facilities offering antimycotic treatments |
8.5 Patient adherence to prescribed antimycotic drug regimens |
9 United Kingdom (UK) Antimycotic Drugs Market - Opportunity Assessment |
9.1 United Kingdom (UK) Antimycotic Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 United Kingdom (UK) Antimycotic Drugs Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United Kingdom (UK) Antimycotic Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United Kingdom (UK) Antimycotic Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 United Kingdom (UK) Antimycotic Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Antimycotic Drugs Market - Competitive Landscape |
10.1 United Kingdom (UK) Antimycotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Antimycotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here